
Pfizer Executive David Denton Appointed As Chief Financial Officer Of Nike
Nike has appointed David Denton as its next Chief Financial Officer (CFO), bringing in the Pfizer executive to lead the company’s finance function. The appointment will take effect from August 17, 2026.
Denton will succeed Matthew Friend, who will remain with Nike until September 4 to support the leadership transition.
Denton is CFO and Executive Vice President (EVP) of Pfizer, and a Member of the company’s Executive Leadership Team. With more than 25 years of finance and operational experience, including over two decades in healthcare, Denton has held senior leadership roles at Pfizer, Lowe’s Companies, and CVS Health. At CVS, he played a key role in the integration of Caremark and the acquisition of Aetna. Earlier, he worked with Deloitte Touche Tohmatsu. Denton holds a business administration degree from Kansas State University and an MBA from Wake Forest University.




